🟢 HCW Biologics is trading 5.42% up in pre-market

HCW Biologics is trading 5.42% higher at $1.75 in pre-market, with no new company-specific announcement identified to explain the rebound.

• Shares closed at $1.66 on September 23, 2026.
• The latest notable development remains the September 4 exclusive Akron Biotech distribution agreement for HCW11-006, reported September 8; it is not a fresh catalyst.
• Biotech sentiment is stronger pre-market, while the broader market is lower.